Notify your doctor if you develop breathing difficulties, heart pounding, irregular heartbeat, ringing in the ears, or difficulty urinating while taking this medication.

May cause dizziness especially when rising quickly from a seated or lying position.

Change positions slowly and be careful on stairs.

May cause drowsiness. Use caution engaging in activities requiring alertness.

Precautions:

If you have asthma, glaucoma, an ulcer, difficulty in urinating due to an enlarged prostate gland, heart disease, high blood pressure, seizures,or an overactive thyroid gland, do not use this drug unless your doctor is aware of your condition and directs you to take it.

Limit the use of alcohol or other sedating type medications to avoid excessive drowsiness.

This drug should be used only if clearly needed during pregnancy.

Because this medication appears in breast milk, consult your doctor before breast-feeding. Do not take for several days before allergy testing.

Test results can be affected.

Generic Name: Hydroxyzine

Vistaril 25 mg/ml Vial - Prescription

Hydroxyzine HCl 25 mg/ml Vial - Prescription

Vistaril 50 mg/ml Vial - Prescription

Hydroxyzine HCl 50 mg/ml Vial - Prescription

Hyzine 50 mg/ml Vial - Prescription

Vistacot 50 mg/ml Vial - Prescription

Vistazine 50 mg/ml Vial - Prescription

Neucalm 50 mg/ml Vial - Prescription

Hydroxyzine HCl 50 mg/ml Disposable Syringe - Prescription

Hydroxyzine HCl 25 mg/ml Disposable Syringe - Prescription

Atarax 10 mg/5 ml Syrup - Prescription

Hydroxyzine HCl 10 mg/5 ml Syrup - Prescription

Hydroxyzine HCl 10 mg Tablet - Prescription

Atarax 100 mg Tablet - Prescription

Hydroxyzine HCl 25 mg Tablet - Prescription

Atarax 50 mg Tablet - Prescription

Hydroxyzine HCl 50 mg Tablet - Prescription

uspi_vistaril

http://www.pfizer.com/download/uspi_vistaril.pdf

hydroxyzine, doses, drug, patients, Vistaril, administration, capsules, hydroxyzine pamoate, therapy, central nervous system, depressant, NDC, elderly patients, agent.

Vistaril is not a cortical depressant, but its action may be due to a suppression of activity in certain key regions of the subcortical area of the central nervous system.

The physician should reassess periodically the usefulness of the drug for the individual patient.

Hydroxyzine, when administered to the pregnant mouse, rat, and rabbit, induced fetal abnormalities in the rat and mouse at doses substantially above the human therapeutic range.

Since drowsiness may occur with use of the drug, patients should be warned of this possibility and cautioned against driving a car or operating dangerous machinery while taking Vistaril (hydroxyzine pamoate).

11795s16

http://www.fda.gov/cder/ogd/rld/11795s16.pdf

hydroxyzine, drug, doses, NDC, capsules, hydroxyzine pamoate, administration, central nervous system, depressant, Vistaril, therapy, oral suspension, patients, dosage.

Vistaril is not a cortical depressant, but its action may be due to a suppression of activity in certain key regions of the subcortical area of the central nervous system.

Hydroxyzine is rapidly absorbed from the gastrointestinal tract and Vistaril's clinical effects are usually noted within 15 to 30 minutes after oral administration.

As a sedative when used as premedication and following general anesthesia, Hydroxyzine may potentiate meperidine (Demerol®) and barbiturates, so their use in pre-anesthetic adjunctive therapy should be modified on an individual basis.

Hydroxyzine, when administered to the pregnant mouse, rat, and rabbit, induced fetal abnormalities in the rat and mouse at doses substantially above the human therapeutic range.

13_1_4.pdf

trichotillomania, treatment, disorder, psychiatry, anxiety, hair, anxiety inventory, hair pulling, hydroxyzine, psychotherapy, patients, adolescents, CTAI, depression.

Objective:Trichotillomania (TM) is a complex psychiatric disorder characterized by repetitive severe hair pulling which may cause hair loss.

The patients were assessed before the treatment and reassessed after one month by using the Children Depression Inventory (CDI), the Children State Anxiety Inventory (CSAI), and the Children Trait Anxiety Inventory (CTAI).

Both psychotherapy and pharmacotherapy are considered to be useful for the treatment of trichotillomania (3,9,11).

The Children Depression Inventory (CDI) is a 27item self-rated symptom oriented scale suitable for use by children and adolescents ranging in age from 7 to 17 years.

This decrease in total CDI scores was not found statistically significant (p>0.05).